Mileen Vasudeo Predicts Nifty Bounce Back & Recommends NeoGen & M&M Stocks | ET Now
5 months ago•ET NOW
Neogen Chemicals - Sanguine Growth Trajectory, Valuations Rich: IDBI Capital
6 months ago•Bloomberg Quint
Neogen Chemicals Q1 Results Review - Long-Term Growth Remains Intact: IDBI Capital
8 months ago•Bloomberg Quint
Neogen Chemicals stock sinks 3% on decline in Q1 profit
8 months ago•Moneycontrol
Neogen Chemicals' Revenue At Rs 900 to 1,050 Crore By FY25-26, Says Harin Kanani | BQ Prime
9 months ago•BQ Prime
Neogen Chemicals' Harin Kanani On Electrolytes' Promoting Growth | BQ Prime
9 months ago•BQ Prime
Neogen Chem plunges 5% on disappointing quarterly performance
11 months ago•Moneycontrol